Press Releases
Vetter introduces South Korea’s pharma and biotech community to meet company management
In an event at its new branch office attended by key customers and business associates, Vetter’s senior management representatives presented the company’s service portfolio along with its growth strategy for South Korea and the Asia Pacific (APAC) region. ...
Press Releases
Cobra Biologics and Symbiosis awarded £1.9m ($2.5m USD) Innovate UK Grant
Cobra Biologics (Cobra), an international contract development and manufacturing organisation (CDMO) of biologics and pharmaceuticals, and Symbiosis Pharmaceutical Services (Symbiosis), a contract manufacturing organisation (CMO) specialising in sterile Fill Finish, announced that they have been awarded a 16-month collaborative...
Press Releases
UPM Raflatac’s insightful pharmaceutical and healtcare labeling at Pharmapack 2018
UPM Raflatac's pharmaceutical and healthcare labeling experts will be present at Pharmapack exhibition on 7-8 February 2018 in Paris, France. Visitors on stand B18 will have the opportunity to see and discuss labeling solutions specified for...
Press Releases
Lonza to Present Latest Research into More Physiologically Relevant ADME-Tox Models at the Society of Toxicology Meeting
During the Society of Toxicology Meeting from 11-15 March 2018 at the Henry B. González Convention Center in San Antonio, TX (USA), Lonza will present two posters highlighting its latest research into developing more physiologically relevant in vitro cell-culture...
Press Releases
Elsevier Welcomes Six Biotech and Pharma Start-ups to The Hive, Supporting the Most Cutting-edge Research in Industry
Elsevier, the global information analytics business specializing in science and health,announced that six start-up companies have been selected from more than 150 global applicants for The Hive, Elsevier's innovation initiative for biotech and pharmaceutical start-ups. Exscientia,...
Press Releases
FDA approves Treatment: Lutathera® Gastroenteropancreatic Neuroendocrine Tumors
Novartis AG announced that Advanced Accelerator Applications, a subsidiary of Novartis Groupe S.A., has received US FDA approval of its NDA for Lutathera® (lutetium Lu 177 dotatate*) for the treatment of somatostatin receptor positive gastroenteropancreatic neuroendocrine tumors (GEP-NETs), including...
Press Releases
NuVasive Extends Its Leadership As Lateral Spine Technology Innovator With New Lateral Single-Position Surgery Procedure
NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, announced new lateral solutions that enable surgeons to perform lateral single-position surgery and expand the Company’s comprehensive lateral portfolio....
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read